YOTTA CAPITAL & OUEST CROISSANCE take majority stake in Les Laboratoires Herbolistique

A consortium formed by lead sponsor Yotta Capital Partners, investing through its Yotta Sustainable Industries 2 fund, and regional private equity firm Ouest Croissance completed a secondary leveraged buyout to acquire a majority equity stake in natural supplements provider Nobilea Group, which comprises Laboratoires Herbolistique, Vallée Nature, and JRV. Under the transaction structure where Yotta deployed 2.5 times the capital committed by Ouest Croissance from a fund deploying tickets between €8 million and €15 million, exiting majority shareholder NCI fully divested its equity interest held since 2021 while rolling over into a mezzanine debt tranche alongside Demea Agro. Historic co-investors Bpifrance and Océan Participations reinvested alongside Group President Michel Mencarelli and executive management. Intermediated by Oaklins and announced on July 30, 2026, the transaction was leveraged with senior debt provided by a syndicate of five regional banking institutions. At closing timing, Nobilea posted annual revenues exceeding €14 million, generated an EBITDA of €0–5M in 2024, employed approximately 60 people, and distributed over 300 natural health product formulations across three European countries. The group operates a vertically integrated industrial manufacturing model following its 2024 acquisitions of contract development and manufacturing businesses Vallée Nature and JRV. The new ownership structure is designed to finance the modernization of manufacturing facilities, scale third-party CDMO operations, and pursue international buy-and-build opportunities, with the company entering exclusive negotiations with two European targets to complete an initial add-on acquisition in late 2026.